Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple breath test could spot pancreatic cancer sooner

NCT ID NCT07243262

First seen Nov 21, 2025 · Last updated Jun 22, 2026 · Updated 28 times

Summary

This study is testing a non-invasive breath test to detect pancreatic cancer earlier. Researchers will collect breath samples from over 6,000 people referred for possible pancreatic cancer. The test looks for tiny molecules made by cancer cells. If accurate, it could help doctors quickly identify who needs further testing.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Imperial College Healthcare NHS Trust

    RECRUITING

    London, United Kingdom

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

breath test

What this could lead to

If successful, this breath test could help doctors detect pancreatic cancer earlier, potentially improving treatment options and survival.

What could go wrong

This is a validation study, not a treatment trial. The test may not be accurate enough in a large population, and false positives or negatives could occur.

Conditions

The condition(s) this trial relates to.

pancreatic ductal adenocarcinoma pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.